Affibody and National Cancer Institute, NIH, to Develop Molecular In Vivo Imaging Agents for Detection of Cancer

09-Nov-2005 - Affibody AB announced a cooperative agreement with the NCI/NIH on the development of conjugates with Affibody® molecules to be used for in vivo imaging of cancers over-expressing HER2. The collaboration is a Cooperative Research and Development Agreement (CRADA) with the Radiation Oncology Branch ...

ChemDiv, Inc. and ProQinase GmbH to Partner in Lead Discovery and Preclinical Development in Oncology

08-Nov-2005 - ChemDiv, Inc. and ProQinase GmbH Germany, announced that they have signed an agreement to establish a partnership in the discovery and preclinical development of new kinase inhibitors. Under the agreement ChemDiv will support design and synthesis of target-focused small molecule libraries, ...

Max Planck Institute and Cellomics Announce Collaboration for High Content Screening Development

03-Nov-2005 - The Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), located in Dresden, Germany, and Cellomics, a unit of Fisher Biosciences, recently announced a joint collaboration in the field of High Content Screening (HCS). The institute serves as a hub for numerous academic-industry ...

PharmacoDesign Purchases Illumina Genotyping Solutions for Pharmacogenomics Research

Illumina to Gain Exclusive, Licensed Access to Biomarkers Discovered Through Disease Studies

27-Oct-2005 - Illumina, Inc. announced an agreement of sale with PharmacoDesign (PD) for a BeadStation system and whole-genome genotyping arrays and reagents for ongoing pharmacogenomics studies. PharmacoDesign will genotype various Korean populations with the aim of understanding genetic variation and ...

Methamphetamine/Ecstasy Detection Patent & Product Launch

27-Oct-2005 - Cozart plc announced that the UK Patent Office has granted its patent for the detection of the Methamphetamine group of drugs. The technology covered by this patent is used in the new Cozart methamphetamine/ecstasy powders test, one of a family of such tests being launched for sale. Other powders ...

Hesperion announces the opening of its Central and Eastern European Regional Office in Warsaw, Poland

24-Oct-2005 - Hesperion Ltd of Allschwil Switzerland, announced the opening of the office of Hesperion sp. z o.o., its fully-owned subsidiary based in Warsaw, Poland. Hesperion's new Polish office will manage all future Central and Eastern European operations for Hesperion. Hesperion employs both office-based ...

SEQUENOM Secures Rights to Key Non-Invasive Prenatal Diagnostic Intellectual Property

24-Oct-2005 - SEQUENOM, Inc. has acquired exclusive rights in certain countries including the United States, United Kingdom and other countries in Europe and elsewhere, to non-invasive prenatal diagnostic intellectual property from Isis Innovation Ltd., the technology transfer company of the University of ...

Lab21 secures additional IP for Hepatitis C diagnostics

21-Oct-2005 - Lab 21 announced that it has completed an agreement to exclusively license the Hepatitis C (HCV) diagnostic technology and associated patent applications of Dr. Carol Holland (TROY, MI, USA). The deal was brokered by UTEK-EKMS (CAMBRIDGE, MA, USA), a leading intellectual property (IP) management ...

Innogenetics acquires full PCR license from Roche Diagnostics

20-Oct-2005 - Innogenetics and Roche Diagnostics announced that they have signed an agreement by which Roche has granted Innogenetics a full, worldwide license for the use of its patented polymerase chain reaction (PCR) technology in the development and commercialization of Innogenetics' molecular diagnostic ...

Dharmacon and 10 Research Institutes Establish Global Initiative to Advance Research Using Human-Genom-Wide siRNA Library

Founding Members Include Leading Biomedical Research Institutes in Six Countries

07-Oct-2005 - Dharmacon, Inc. announced the formation of the Genome-Wide RNAi Global Initiative, an alliance of leading international biomedical research centers. The initial goal of the Global Initiative is to accelerate the scientific and medical discoveries made possible by the recent availability of the ...